TokenPost·
PROCEPT BioRobotics Targets Positive Adjusted EBITDA in Q4 2026
The company projects 2026 revenue of $390 million to $410 million and a full-year adjusted EBITDA loss of $30 million to $35 million.
More news
- TokenPostEnergy Fuels Posts $52.37 Million Q3 Loss as Revenue Rises
- crypto.newsBNB Chain, Base respond to Reth security bug affecting EVM networks
- CryptonewsLIVE- Wall Street Power Grab? Anti-Crypto Elizabeth Warren Could Put Day Trading in the Crosshairs
- TokenPostSouth Korean Finance Authorities Will Track U.S. AI Policy After Midterm Elections
- TokenPostFOMO Perpetual Trading Volume Sets $414.9 Million Daily Record
- TokenPostGREEN MORNING (GM) Rises More Than 400% in Brief Nov. 6 Move